Trial intelligence / Profile preview

Magnesium for Prevention of Contrast-Induced Nephropathy

IRCT20250706066386N1Phase 3Completed

Sponsor
Islamic Azad University, Sari Branch
Start
Jul 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium in contrast-induced nephropathy (CIN), sponsored by Islamic Azad University, Sari Branch. Started Jul 2025; status: completed.

02

Drugs

magnesium
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on IRCT20250706066386N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250706066386N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call